![](/img/cover-not-exists.png)
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
Santoro, A., Gebbia, V., Pressiani, T., Testa, A., Personeni, N., Arrivas Bajardi, E., Foa, P., Buonadonna, A., Bencardino, K., Barone, C., Ferrari, D., Zaniboni, A., Tronconi, M. C., Carteni, G., MilVolume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu576
Date:
March, 2015
File:
PDF, 201 KB
english, 2015